The end of research-or just the end of research as we know it?

Nuclear Medicine Communications

Volumn 25, Issue 4, 2004, Pages 329-331

  Elliott, Alex ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CERTIFICATION; CLINICAL PRACTICE; CLINICAL RESEARCH; EDITORIAL; GOOD MANUFACTURING PRACTICE; HEALTH PROGRAM; HUMAN; INFORMED CONSENT; PRACTICE GUIDELINE; RESEARCH ETHICS;

BIOTECHNOLOGY; CLINICAL TRIALS; DRUG INDUSTRY; GREAT BRITAIN; GUIDELINES; HUMANS; RADIOPHARMACEUTICALS; RESEARCH; RESEARCH DESIGN;

EID: 2142770342     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200404000-00003     Document Type: Editorial

References (6)

1. Statutory Instrument (draft). The Medicines for Human Use (Clinical Trials) Regulations 2003. London: The Stationery Office Ltd; 2003.
2. European Commission. Directive 2001/20/EC of the European Parliament and Council on the approximation of the laws, Regulations and administrative provisions of the Member States relating to implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Luxembourg: European Commission.
3. European Commission. Detailed guidance for the request for authorisation of a clinical trial on a medicinal product for human use to the competent authorities, notification of substantial amendments and declaration of the end of the trial. ENTR/F2/BL D (2003). Luxembourg: European Commission.
4. The Medicines Act 1968. London: HMSO; 1968.
5. http://medicines.mhra.gov.uk/ourwork/licensingmeds/types/clintrialdir.htms
6. http://www.corec.org.uk